Effects of Decitabine on the expression of immune checkpoint molecules, immune cell function and the tumormicroenvironment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2024
- Schlagwort
-
Immunsystem
Krebs
T-Lymphozyt
Immunreaktion
Modell
Plattenepithelkarzinom
Decitabin
Immun-Checkpoint
Immuntherapie
- DOI
-
10.18725/OPARU-55294
- URN
-
urn:nbn:de:bsz:289-oparu-55369-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
20.07.0008, 03:31 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fehn, Adrian
- Universität Ulm
Entstanden
- 2025
Ähnliche Objekte (12)
Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Expression of immune checkpoint molecules on adult and neonatal T-cells
Expression of immune checkpoint molecules on adult and neonatal T-cells
Monalizumab: inhibiting the novel immune checkpoint NKG2A
The CD83 Molecule – An Important Immune Checkpoint
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Expression of immune checkpoint molecules on adult and neonatal T-cells
Expression of immune checkpoint molecules on adult and neonatal T-cells
Monalizumab: inhibiting the novel immune checkpoint NKG2A
The CD83 Molecule – An Important Immune Checkpoint
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Expression of immune checkpoint molecules on adult and neonatal T-cells
Expression of immune checkpoint molecules on adult and neonatal T-cells
Monalizumab: inhibiting the novel immune checkpoint NKG2A
The CD83 Molecule – An Important Immune Checkpoint
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis